Seguir
Yasin Şenbabaoğlu
Yasin Şenbabaoğlu
Genentech
Dirección de correo verificada de gene.com
Título
Citado por
Citado por
Año
The Cancer Genome Atlas Pan-Cancer analysis project
TCGA Network, JN Weinstein, EA Collisson, GB Mills, KRM Shaw, ...
Nature Genetics 45 (10), 1113–1120, 2013
6407*2013
Comprehensive molecular characterization of gastric adenocarcinoma
TCGA Network
Nature 513 (7517), 202-209, 2014
50922014
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, Turley, Nickles, Castiglioni, Yuen, Wang, Kadel, Koeppen, ...
Nature, 2018
37112018
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas
Cancer Genome Atlas Research Network
New England Journal of Medicine 372 (26), 2481-2498, 2015
28792015
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
26572015
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
TCGA Network
Cell 159 (3), p676-690, 2014
2486*2014
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1662*2020
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.
KA Hoadley, et al.
Cell 158 (4), 929-44, 2014
15232014
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
TCGA Network
Cancer Cell 32 (2), 185-203, 2017
15202017
Emerging landscape of oncogenic signatures across human cancers
G Ciriello, ML Miller, BA Aksoy, Y Senbabaoglu, N Schultz, C Sander
Nature genetics 45 (10), 1127-1133, 2013
14852013
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ...
Nature, 2017
9862017
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
TCGA Network
Cell 171 (4), 950-965, 2017
7882017
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Y Şenbabaoğlu, RS Gejman, AG Winer, M Liu, EM Van Allen, ...
Genome biology 17, 1-25, 2016
7882016
The head and neck cancer immune landscape and its immunotherapeutic implications
R Mandal, Y Senbabaoglu, A Desrichard, et al.
JCI Insight 1 (17), 2016
6762016
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy
CX Dominguez, S Müller, S Keerthivasan, H Koeppen, J Hung, S Gierke, ...
Cancer discovery 10 (2), 232-253, 2020
5192020
Mitochondrial DNA copy number variation across human cancers
E Reznik, M Miller, Y Şenbabaoğlu, N Riaz, J Sarungbam, S Tickoo, ...
eLife 5 (e10769), 2016
4492016
Multilevel genomics-based taxonomy of renal cell carcinoma
F Chen, Y Zhang, Y Şenbabaoğlu, G Ciriello, L Yang, E Reznik, B Shuch, ...
Cell reports 14 (10), 2476-2489, 2016
3392016
Critical limitations of consensus clustering in class discovery
Y Senbabaoglu, G Michailidis, JZ Li
Scientific Reports 4, 2014
3042014
Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival
L Morris, N Riaz, A Desrichard, Y Şenbabaoğlu, A Hakimi, V Makarov, ...
Oncotarget, 2016
2902016
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours
R Zappasodi, I Serganova, IJ Cohen, M Maeda, M Shindo, ...
Nature 591 (7851), 652-658, 2021
2262021
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20